With NIH “Accountability” As Background, Advocates Support Budget Increases.
Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.
Bush Nominates VA Official For HHS Deputy Secretary.
Stronger Anti-Smoking Efforts Needed For Women, SG Says.
Meharry, Vanderbilt Win Grant For Research Collaboration.
FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.
US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.
Firm Begins Phase II Trial Of LDP-341 For Myeloma.
Faulding, NaPro In Agreement For Marketing Paclitaxel.
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya